Schizoaffective Disorders Terminated Phase 3 Trials for Aripiprazole (DB01238)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00288353Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic ChangesTreatment
NCT00857818Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic SyndromeTreatment